References
Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208(8):1635–48.
van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LAB, Gilissen C, et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med. 2011;365(1):54–61.
Toubiana J, Okada S, Hiller J, Oleastro M, Lagos Gomez M, Aldave Becerra JC, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127(25):3154–64.
Uzel G, Sampaio EP, Lawrence MG, Hsu AP, Hackett M, Dorsey MJ, et al. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome. J Allergy Clin Immunol. 2013;131(6):1611–23.
Rutsch F, MacDougall M, Lu C, Buers I, Mamaeva O, Nitschke Y, et al. A specific IFIH1 gain-of-function mutation causes Singleton-Merten syndrome. Am J Hum Genet. 2015;96(2):275–82.
Al Shehri T, Abinun M, Gennery AR, et al. Is gain-of-function STAT1 CMC an interferonopathy? Clin Exp Immunol. 2015;182(S1):15.
Higgins E, Al Shehri T, McAleer MA, et al. Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation. J Allergy Clin Immunol. 2015;135(2):551–3.
Acknowledgements
We wish to acknowledge the assistance of our colleagues in the Northern Molecular Genetics Service in Newcastle-upon-Tyne and the advice of Drs Anne Puel, Yannick Crow, and J.L Casanova. Finally, we wish to acknowledge the goodwill of the patient and her family.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of Interest
The authors declare that they have no conflicts of interest.
Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Smyth, A.E., Kaleviste, E., Snow, A. et al. Aortic Calcification in a Patient with a Gain-of-Function STAT1 Mutation. J Clin Immunol 38, 468–470 (2018). https://doi.org/10.1007/s10875-018-0513-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-018-0513-z